Sight Sciences SGHT
NASDAQ SGHT
$8.32 -0.15 (-1.77%)
At close: Aug 20, 2026 · 11:14 AM UTC

Sight Sciences (SGHT) Net Income towards Common Stockholders (2020 - 2026)

Sight Sciences (SGHT) posted quarterly Net Income towards Common Stockholders of -$13.0 million for Q1 2026, up 8.29% year-over-year from -$12.0 million in Q1 2025, and down 211.87% quarter-over-quarter from -$4.2 million in Q4 2025.

Sight Sciences (SGHT) Net Income towards Common Stockholders (2020 - 2026) Analysis & Trends

Sight Sciences' Net Income towards Common Stockholders history runs 7 years deep, the most recent figure standing at -$13.0 million for Q1 2026.

  • In Q1 2026, Net Income towards Common Stockholders rose 8.29% year-over-year to -$13.0 million; the TTM figure through Mar 2026 stood at -$37.3 million (up 24.58% YoY), while the FY2025 annual figure was -$38.4 million, up 25.4% from the prior year.
  • Net Income towards Common Stockholders for Q1 2026 stood at -$13.0 million, down from -$4.2 million in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was -$4.2 million in Q4 2025, with the low at -$23.8 million in Q2 2022.
  • The 5-year median for Net Income towards Common Stockholders is -$13.0 million (2023), against an average of -$14.4 million.
  • The sharpest annual moves came in 2022 and 2025: Net Income towards Common Stockholders sank 90.06% in 2022, then soared 64.87% in 2025.
  • Sight Sciences' Net Income towards Common Stockholders stood at -$16.9 million in 2022, then surged by 36.77% to -$10.7 million in 2023, then declined by 10.8% to -$11.8 million in 2024, then jumped by 64.87% to -$4.2 million in 2025, then slumped by 211.87% to -$13.0 million in 2026.
  • Business Quant data shows SGHT's Net Income towards Common Stockholders at -$13.0 million in Q1 2026, -$4.2 million in Q4 2025, and -$8.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 200.20 Bn 194.60 Bn 7.27 Bn 928.00 Mn
2 Stryker 129.69 Bn 126.21 Bn 4.50 Bn 1.28 Bn
3 Medtronic 120.14 Bn 110.92 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 74.16 Bn 73.62 Bn 3.85 Bn 907.00 Mn
5 Edwards Lifesciences 52.68 Bn 48.43 Bn 1.35 Bn 241.40 Mn
6 Dexcom 34.57 Bn 32.62 Bn 830.00 Mn 249.10 Mn
7 GE HealthCare Technologies 34.09 Bn 31.98 Bn 2.18 Bn 574.00 Mn
8 Koninklijke Philips 26.49 Bn 23.17 Bn 4.55 Bn 621.86 Mn
9 Steris 23.19 Bn 22.70 Bn 684.20 Mn 201.00 Mn
10 Sight Sciences 453.49 Mn 373.74 Mn 21.37 Mn -4.45 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.45 Mn
Mar 31, 2026 -12.98 Mn
Dec 31, 2025 -4.16 Mn
Sep 30, 2025 -8.17 Mn
Jun 30, 2025 -11.94 Mn
Mar 31, 2025 -14.15 Mn
Dec 31, 2024 -11.85 Mn
Sep 30, 2024 -11.07 Mn
Jun 30, 2024 -12.33 Mn
Mar 31, 2024 -16.27 Mn
Dec 31, 2023 -10.69 Mn
Sep 30, 2023 -13.04 Mn
Jun 30, 2023 -14.75 Mn
Mar 31, 2023 -17.07 Mn
Dec 31, 2022 -16.91 Mn
Sep 30, 2022 -22.23 Mn
Jun 30, 2022 -23.84 Mn
Mar 31, 2022 -23.26 Mn
Dec 31, 2021 -15.94 Mn
Sep 30, 2021 -17.17 Mn